Medtronic Vanta Neurostimulator Recall for Premature Battery Depletion
Medtronic is recalling Vanta Implantable Neurostimulators (Model 977006) because battery life depleted faster than expected, leading to earlier surgical replacements or reprogramming.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves a risk-of-harm product (implantable device) where the defect leads to earlier surgical intervention, but no specific injuries or deaths are reported in the source text.
Plain-English summary
Medtronic Neuromodulation is recalling 11,789 units of the Vanta Implantable Neurostimulator (INS), Model 977006. The recall was initiated because the battery life of these devices has depleted faster than healthcare providers or patients expected.
This issue has led to outpatient reprogramming or surgical replacements occurring earlier than anticipated. The affected devices were distributed worldwide.
Patients with this specific model should contact their healthcare provider to discuss the recall and determine if their device requires monitoring or intervention. The recall is classified as Class II by the FDA.
The recalled product
- Product
- Vanta Implantable Neurostimulator (INS), Model 977006
- Manufacturer
- Medtronic Neuromodulation
- Affected units
- 11,789
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- UDI/DI 00763000411923
- Serial Numbers: NMS500122H
- NMS500123H
- NMS500130H
- NMS500135H
- NMS500159H
- NMS500190H
- NMS500191H
- NMS500194H
- NMS500201H
- NMS500309H
- NMS500310H
- NMS500312H
- NMS500313H
- NMS500314H
- NMS500315H
- NMS500316H
- NMS500317H
- NMS500318H
- NMS500319H
Distribution
Distribution scope not specified by the agency.
Related recalls
Same manufacturer · Medtronic Neuromodulation
See all →- ModerateMedtronic 2x4 pocket adaptor kits carry incorrect use-by dates
FDA (Devices) · 2026-06-03
- ModerateMedtronic 1x4 pocket adaptor kits carry incorrect use-by dates
FDA (Devices) · 2026-06-03
- HighMedtronic SynchroMed Flex Infusion Programmer Software Application
FDA (Devices) · 2026-05-20
- ModerateNeurostimulator clinician programmer app recalled over faults during device use
FDA (Devices) · 2026-01-21
- HighFemoral nails, 360 mm left trochanteric, recalled over undersized shaft diameter
FDA (Devices) · 2025-12-31
Same hazard · premature battery depletion
See all →- SevereSt Jude Medical Recalls ICD and CRT-D Devices for Battery Short Circuit
FDA (Devices) · 2016-11-02
- HighBoston Scientific COGNIS CRT-D Recall for Premature Battery Depletion
FDA (Devices) · 2014-10-29
Similar recalls
- HighMedtronic RestoreSensor Implantable Neurostimulators Recalled for Battery Depletion
FDA (Devices) · 2016-06-15
- HighVanta INS Neurostimulator May Fail to Communicate with Programmer Systems
FDA (Devices) · 2022-06-01
- HighMedtronic Activa Neurostimulators Recalled for Loss of Stimulation
FDA (Devices) · 2013-11-20
- HighMedtronic RestoreUltra and RestoreSensor Neurostimulators Recalled for Loss of Stimulation
FDA (Devices) · 2013-11-20
- HighMedtronic Recharger Kits Recalled for Potential Failure to Initiate Recharging
FDA (Devices) · 2024-11-20
- HighMedtronic Intellis Recharger Recalled for Potential Unintended Heating
FDA (Devices) · 2021-05-12